Dermavant Sciences, Inc. announced that the US FDA accepted the company’s sNDA for VTAMA® cream, 1% for the topical treatment of atopic dermatitis in adults and children two years of age and older.
[Dermavant Sciences, Inc.]
Home Newsletters Dermal Cell News Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA®...
